BioLife Solutions (BLFS) Misses Q2 EPS by 30c ; Offers Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $36.69 -0.43%
EPS Growth %: +400.0%
Financial Fact:
Gross profit: 1.21M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +400.0%
Financial Fact:
Gross profit: 1.21M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q2 EPS of ($0.33), $0.30 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $25.42 million versus the consensus estimate of $23.71 million.
GUIDANCE:
BioLife Solutions sees FY2025 revenue of $100-103 million, versus the consensus of $97.76 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Fold Holdings (FLD) files for 51.23M share offering by selling stockholders
- Leidos wins $85m Air Force contract for aerospace design
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
